GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eco Animal Health Group PLC (LSE:EAH) » Definitions » Debt-to-Asset

Eco Animal Health Group (LSE:EAH) Debt-to-Asset : 0.03 (As of Sep. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Eco Animal Health Group Debt-to-Asset?

Eco Animal Health Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was £0.57 Mil. Eco Animal Health Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was £3.08 Mil. Eco Animal Health Group's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was £111.73 Mil. Eco Animal Health Group's debt to asset for the quarter that ended in Sep. 2024 was 0.03.


Eco Animal Health Group Debt-to-Asset Historical Data

The historical data trend for Eco Animal Health Group's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eco Animal Health Group Debt-to-Asset Chart

Eco Animal Health Group Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.01 0.02 0.04 0.03

Eco Animal Health Group Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.04 0.04 0.03 0.03

Competitive Comparison of Eco Animal Health Group's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Eco Animal Health Group's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eco Animal Health Group's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eco Animal Health Group's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Eco Animal Health Group's Debt-to-Asset falls into.



Eco Animal Health Group Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Eco Animal Health Group's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.646 + 3.379) / 123.265
=0.03

Eco Animal Health Group's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eco Animal Health Group  (LSE:EAH) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Eco Animal Health Group Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Eco Animal Health Group's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Eco Animal Health Group Business Description

Traded in Other Exchanges
Address
100 High street, The Grange, Southgate, London, GBR, N14 6BN
Eco Animal Health Group PLC is engaged in manufacturing and marketing animal health products. The company's product portfolio includes Aivlosin - macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry; Ecomectin, Eco heart, Ecotraz, and Ecomintic for treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry and cattle. The company's geographical segments include Corporate/UK, China & Japan, North America, South & South East Asia, Latin America, Europe, and the Rest of the World. Maximum revenue for the company is generated from China and Japan.

Eco Animal Health Group Headlines

No Headlines